Unraveling the Role of Angiogenesis in Cancer Ecosystems
暂无分享,去创建一个
[1] B. Lasseter. Assays , 2019, Nature Biotechnology.
[2] Janice A. Gasker. Therapeutic Implications , 2019, “I Never Told Anyone This Before”.
[3] Milad Shamsi,et al. Translational models of tumor angiogenesis: A nexus of in silico and in vitro models. , 2018, Biotechnology advances.
[4] Robert J. Griffin,et al. Consensus guidelines for the use and interpretation of angiogenesis assays , 2018, Angiogenesis.
[5] D. Noonan,et al. Contribution to Tumor Angiogenesis From Innate Immune Cells Within the Tumor Microenvironment: Implications for Immunotherapy , 2018, Front. Immunol..
[6] A. Zippelius,et al. The multi-receptor inhibitor axitinib reverses tumor-induced immunosuppression and potentiates treatment with immune-modulatory antibodies in preclinical murine models , 2018, Cancer Immunology, Immunotherapy.
[7] P. Hegde,et al. Predictive markers of anti-VEGF and emerging role of angiogenesis inhibitors as immunotherapeutics. , 2017, Seminars in cancer biology.
[8] Hellmut G. Augustin,et al. Preclinical mouse solid tumour models: status quo, challenges and perspectives , 2017, Nature Reviews Cancer.
[9] C. Bokemeyer,et al. Mast cells decrease efficacy of anti-angiogenic therapy by secreting matrix-degrading granzyme B , 2017, Nature Communications.
[10] T. Petrova,et al. Microenvironmental regulation of tumour angiogenesis , 2017, Nature Reviews Cancer.
[11] D. Ribatti,et al. Mast cells in breast cancer angiogenesis. , 2017, Critical reviews in oncology/hematology.
[12] Bruno Larrivée,et al. Tumor angiogenesis and vascular normalization: alternative therapeutic targets , 2017, Angiogenesis.
[13] D. Gabrilovich,et al. Dendritic cells in cancer: the role revisited. , 2017, Current opinion in immunology.
[14] K. Pantel,et al. Circulating and disseminated tumour cells — mechanisms of immune surveillance and escape , 2017, Nature Reviews Clinical Oncology.
[15] Yiping Yang,et al. Tumor-associated macrophages: implications in cancer immunotherapy. , 2017, Immunotherapy.
[16] Ming Ding,et al. Bone Formation by Sheep Stem Cells in an Ectopic Mouse Model: Comparison of Adipose and Bone Marrow Derived Cells and Identification of Donor-Derived Bone by Antibody Staining , 2016, Stem cells international.
[17] Ignace Vergote,et al. Final results of a phase 3 study of trebananib plus weekly paclitaxel in recurrent ovarian cancer (TRINOVA-1): Long-term survival, impact of ascites, and progression-free survival-2. , 2016, Gynecologic oncology.
[18] Jennie W. Taylor,et al. Abstract LB-347: Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival , 2016 .
[19] W. ElShamy,et al. Aggressiveness Niche: Can It Be the Foster Ground for Cancer Metastasis Precursors? , 2016, Stem cells international.
[20] A. Azab,et al. The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy , 2015, Hypoxia.
[21] Bjorn Baselet,et al. Metabolic changes associated with tumor metastasis, part 1: tumor pH, glycolysis and the pentose phosphate pathway , 2015, Cellular and Molecular Life Sciences.
[22] Rakesh K. Jain,et al. Role of vascular density and normalization in response to neoadjuvant bevacizumab and chemotherapy in breast cancer patients , 2015, Proceedings of the National Academy of Sciences.
[23] P. Carmeliet,et al. Angiogenesis Revisited: An Overlooked Role of Endothelial Cell Metabolism in Vessel Sprouting , 2015, Microcirculation.
[24] V. Rosti,et al. Endothelial progenitor cells support tumour growth and metastatisation: implications for the resistance to anti-angiogenic therapy , 2015, Tumor Biology.
[25] T. Maeda,et al. Acidic extracellular pH promotes epithelial mesenchymal transition in Lewis lung carcinoma model , 2014, Cancer Cell International.
[26] R. Jain. Antiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia. , 2014, Cancer cell.
[27] D. Ribatti. The chick embryo chorioallantoic membrane as a model for tumor biology. , 2014, Experimental cell research.
[28] R. Jain,et al. The role of mechanical forces in tumor growth and therapy. , 2014, Annual review of biomedical engineering.
[29] F. Bianchini,et al. Extracellular acidity, a “reappreciated” trait of tumor environment driving malignancy: perspectives in diagnosis and therapy , 2014, Cancer and Metastasis Reviews.
[30] A. D. Van den Abbeele,et al. Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma , 2014, Cancer Immunology Research.
[31] B. Rini,et al. Angiogenesis and the tumor microenvironment: vascular endothelial growth factor and beyond. , 2014, Seminars in oncology.
[32] J. Brown,et al. Vasculogenesis: a crucial player in the resistance of solid tumours to radiotherapy. , 2014, The British journal of radiology.
[33] C. Fuchs,et al. Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial , 2014, The Lancet.
[34] D. Quail,et al. Microenvironmental regulation of tumor progression and metastasis , 2013, Nature Medicine.
[35] R. Jain,et al. Vascular normalization as an emerging strategy to enhance cancer immunotherapy. , 2013, Cancer research.
[36] Yongzhi Yang,et al. HIFs, angiogenesis, and cancer , 2013, Journal of cellular biochemistry.
[37] S. Sleijfer,et al. Pazopanib, a new therapy for metastatic soft tissue sarcoma , 2013, Expert opinion on pharmacotherapy.
[38] M. Mimeault,et al. Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells , 2013, Journal of cellular and molecular medicine.
[39] R. Watnick. The role of the tumor microenvironment in regulating angiogenesis. , 2012, Cold Spring Harbor perspectives in medicine.
[40] F. Otterbach,et al. New Insight into the SDF-1/CXCR4 Axis in a Breast Carcinoma Model: Hypoxia-Induced Endothelial SDF-1 and Tumor Cell CXCR4 Are Required for Tumor Cell Intravasation , 2012, Molecular Cancer Research.
[41] I. Geudens,et al. Coordinating cell behaviour during blood vessel formation , 2011, Development.
[42] J. Italiano,et al. Release of angiogenesis regulatory proteins from platelet alpha granules: modulation of physiologic and pathologic angiogenesis. , 2011, Blood.
[43] P. Carmeliet,et al. Molecular mechanisms and clinical applications of angiogenesis , 2011, Nature.
[44] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[45] R. Kelly,et al. Target Inhibition in Antiangiogenic Therapy A Wide Spectrum of Selectivity and Specificity , 2010, Cancer journal.
[46] Xin Lu,et al. Hypoxia and Hypoxia-Inducible Factors: Master Regulators of Metastasis , 2010, Clinical Cancer Research.
[47] Min-Ying Su,et al. Characterization of Pure Ductal Carcinoma In Situ on Dynamic Contrast-Enhanced MR Imaging: Do Nonhigh Grade and High Grade Show Different Imaging Features? , 2010, Journal of oncology.
[48] Michael C. Schmid,et al. Myeloid Cells in the Tumor Microenvironment: Modulation of Tumor Angiogenesis and Tumor Inflammation , 2010, Journal of oncology.
[49] D. Ingber,et al. Tumor growth and angiogenesis are dependent on the presence of immature dendritic cells , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[50] Hans-Peter Lipp,et al. Tyrosine kinase inhibitors - a review on pharmacology, metabolism and side effects. , 2009, Current drug metabolism.
[51] J. Knox,et al. Sunitinib in solid tumors , 2009, Expert opinion on investigational drugs.
[52] C. Betsholtz,et al. Endothelial-mural cell signaling in vascular development and angiogenesis. , 2009, Arteriosclerosis, thrombosis, and vascular biology.
[53] R. Weinberg,et al. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits , 2009, Nature Reviews Cancer.
[54] V. Bautch. Endothelial Cells Form a Phalanx to Block Tumor Metastasis , 2009, Cell.
[55] N. Ferrara,et al. Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies. , 2008, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[56] P. Comoglio,et al. Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages , 2008, The Journal of experimental medicine.
[57] R. Folberg,et al. Demonstrating circulation in vasculogenic mimicry patterns of uveal melanoma by confocal indocyanine green angiography , 2008, Eye.
[58] W. Gerald,et al. TGFβ Primes Breast Tumors for Lung Metastasis Seeding through Angiopoietin-like 4 , 2008, Cell.
[59] M. Koch,et al. Tumor Escape from Endogenous, Extracellular Matrix–Associated Angiogenesis Inhibitors by Up-Regulation of Multiple Proangiogenic Factors , 2008, Clinical Cancer Research.
[60] J. Folkman,et al. Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. , 2008, Blood.
[61] Holger Gerhardt,et al. Pericytes: gatekeepers in tumour cell metastasis? , 2008, Journal of Molecular Medicine.
[62] D. Jin,et al. Regulation of Vasculogenesis by Platelet-Mediated Recruitment of Bone Marrow–Derived Cells , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[63] E. Sahai,et al. Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells , 2007, Nature Cell Biology.
[64] S. Robinson,et al. The effects of tumor‐derived platelet‐derived growth factor on vascular morphology and function in vivo revealed by susceptibility MRI , 2007, International journal of cancer.
[65] Michal Neeman,et al. In vivo imaging of the systemic recruitment of fibroblasts to the angiogenic rim of ovarian carcinoma tumors. , 2007, Cancer research.
[66] L. Ellis,et al. Overexpression of PDGF-BB decreases colorectal and pancreatic cancer growth by increasing tumor pericyte content. , 2007, The Journal of clinical investigation.
[67] J. Boniver,et al. [Ileum intussusception in an adult: a case report]. , 2007, Revue medicale de Liege.
[68] D. McDonald,et al. Mechanisms of adverse effects of anti-VEGF therapy for cancer , 2007, British Journal of Cancer.
[69] Adam L. Bermange,et al. Endothelial signalling by the Notch ligand Delta-like 4 restricts angiogenesis , 2007, Development.
[70] S. Rafii,et al. Thrombospondins deployed by thrombopoietic cells determine angiogenic switch and extent of revascularization. , 2006, The Journal of clinical investigation.
[71] Wei Zhang,et al. Vasculogenic mimicry is associated with high tumor grade, invasion and metastasis, and short survival in patients with hepatocellular carcinoma. , 2006, Oncology reports.
[72] R. Motzer,et al. Sunitinib in patients with metastatic renal cell carcinoma. , 2006, JAMA.
[73] Holger Gerhardt,et al. Pericytes limit tumor cell metastasis. , 2006, The Journal of clinical investigation.
[74] Birgit Kasch,et al. Next Generation , 2005, Im OP.
[75] L. Chin,et al. Epigenetic transdifferentiation of normal melanocytes by a metastatic melanoma microenvironment. , 2005, Cancer research.
[76] M. Neeman,et al. Functional and molecular mapping of uncoupling between vascular permeability and loss of vascular maturation in ovarian carcinoma xenografts: The role of stroma cells in tumor angiogenesis , 2005, International journal of cancer.
[77] Peter Carmeliet,et al. VEGF as a Key Mediator of Angiogenesis in Cancer , 2005, Oncology.
[78] R. Rudolph,et al. Artificial, non-antibody binding proteins for pharmaceutical and industrial applications. , 2005, Trends in biotechnology.
[79] Z. Werb,et al. PDGFRβ+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival , 2005, Nature Cell Biology.
[80] Daniela S Krause,et al. Tyrosine kinases as targets for cancer therapy. , 2005, The New England journal of medicine.
[81] D. Ribatti,et al. Microvascular density, vascular endothelial growth factor immunoreactivity in tumor cells, vessel diameter and intussusceptive microvascular growth in primary melanoma. , 2005, Oncology reports.
[82] S. Itohara,et al. Contribution of host MMP‐2 and MMP‐9 to promote tumor vascularization and invasion of malignant keratinocytes , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[83] A. Ruddell,et al. Myc regulates VEGF production in B cells by stimulating initiation of VEGF mRNA translation , 2005, Oncogene.
[84] R. Jain. Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy , 2005, Science.
[85] D. Gabrilovich. Mechanisms and functional significance of tumour-induced dendritic-cell defects , 2004, Nature Reviews Immunology.
[86] Ruslan Hlushchuk,et al. Intussusceptive angiogenesis: Its emergence, its characteristics, and its significance , 2004, Developmental dynamics : an official publication of the American Association of Anatomists.
[87] Peter Vaupel,et al. The role of hypoxia-induced factors in tumor progression. , 2004, The oncologist.
[88] S. Dimmeler,et al. Endothelial progenitor cells functional characterization. , 2004, Trends in cardiovascular medicine.
[89] Arjun Deb,et al. Integrin Profile and In Vivo Homing of Human Smooth Muscle Progenitor Cells , 2004, Circulation.
[90] Z. Werb,et al. Regulation of matrix biology by matrix metalloproteinases. , 2004, Current opinion in cell biology.
[91] A. Griffioen,et al. Angiogenesis gene expression profiling in xenograft models to study cellular interactions. , 2004, Experimental cell research.
[92] Masahiro Inoue,et al. An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis. , 2004, The Journal of clinical investigation.
[93] Joe Tien,et al. Mechanotransduction at cell-matrix and cell-cell contacts. , 2004, Annual review of biomedical engineering.
[94] Stefan Walenta,et al. Lactate: mirror and motor of tumor malignancy. , 2004, Seminars in radiation oncology.
[95] R. Folberg,et al. Vasculogenic mimicry , 2004, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[96] J. Foidart,et al. Membrane associated proteases and their inhibitors in tumour angiogenesis , 2004, Journal of Clinical Pathology.
[97] T. Sjöblom,et al. Platelet-derived growth factor production by B16 melanoma cells leads to increased pericyte abundance in tumors and an associated increase in tumor growth rate. , 2004, Cancer research.
[98] M. Salgaller. Technology evaluation: bevacizumab, Genentech/Roche. , 2003, Current opinion in molecular therapeutics.
[99] C. Betsholtz,et al. Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors. , 2003, The Journal of clinical investigation.
[100] Tarik Tihan,et al. The hypoxic response of tumors is dependent on their microenvironment. , 2003, Cancer cell.
[101] Seth M Steinberg,et al. A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer. , 2003, The New England journal of medicine.
[102] M. Seiki,et al. Roles of pericellular proteolysis by membrane type‐1 matrix metalloproteinase in cancer invasion and angiogenesis , 2003, Cancer science.
[103] N. Ferrara,et al. The biology of VEGF and its receptors , 2003, Nature Medicine.
[104] M. Hendrix,et al. Angiogenesis: Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma , 2003, Nature Reviews Cancer.
[105] R. Kalluri. Basement membranes: structure, assembly and role in tumour angiogenesis , 2003, Nature reviews. Cancer.
[106] Rakesh K Jain,et al. Molecular regulation of vessel maturation , 2003, Nature Medicine.
[107] O. Volpert,et al. Wiring the angiogenic switch: Ras, Myc, and Thrombospondin-1. , 2003, Cancer cell.
[108] J. Folkman,et al. Clinical translation of angiogenesis inhibitors , 2002, Nature Reviews Cancer.
[109] S. Rafii,et al. Recruitment of Stem and Progenitor Cells from the Bone Marrow Niche Requires MMP-9 Mediated Release of Kit-Ligand , 2002, Cell.
[110] A. Harris,et al. Tumor-Associated Macrophages in Breast Cancer , 2002, Journal of Mammary Gland Biology and Neoplasia.
[111] Rakesh K Jain,et al. Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. , 2002, The American journal of pathology.
[112] Z. Werb,et al. New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.
[113] S. Rafii,et al. The Id proteins and angiogenesis , 2001, Oncogene.
[114] Mina J. Bissell,et al. Putting tumours in context , 2001, Nature Reviews Cancer.
[115] J. Abbruzzese,et al. Regulation of vascular endothelial growth factor expression by acidosis in human cancer cells , 2001, Oncogene.
[116] Elise C. Kohn,et al. The microenvironment of the tumour–host interface , 2001, Nature.
[117] M J Bissell,et al. Tumors are unique organs defined by abnormal signaling and context. , 2001, Seminars in cancer biology.
[118] Peter C. Brooks,et al. New Functions for Non-collagenous Domains of Human Collagen Type IV , 2000, The Journal of Biological Chemistry.
[119] P. Meltzer,et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. , 1999, The American journal of pathology.
[120] N. Ferrara. Role of vascular endothelial growth factor in the regulation of angiogenesis. , 1999, Kidney international.
[121] T. Shono,et al. Macrophage infiltration and heme oxygenase-1 expression correlate with angiogenesis in human gliomas. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[122] R. Xavier,et al. Tumor Induction of VEGF Promoter Activity in Stromal Cells , 1998, Cell.
[123] H. Kroemer,et al. Elucidation of the mechanism enabling tumor selective prodrug monotherapy. , 1998, Cancer research.
[124] L. Matrisian,et al. Changing views of the role of matrix metalloproteinases in metastasis. , 1997, Journal of the National Cancer Institute.
[125] Harold E. Dvorak,et al. Angiogenesis: a Dynamic Balance of Stimulators and Inhibitors , 1997, Thrombosis and Haemostasis.
[126] W. Risau,et al. Mechanisms of angiogenesis , 1997, Nature.
[127] D. Hanahan,et al. Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.
[128] R. Hildenbrand,et al. Urokinase and macrophages in tumour angiogenesis. , 1995, British Journal of Cancer.
[129] R. Kerbel,et al. Consequences of angiogenesis for tumor progression, metastasis and cancer therapy. , 1995, Anti-cancer drugs.
[130] Cord Sunderkötter,et al. Macrophages and angiogenesis , 1994, Journal of leukocyte biology.
[131] J. Folkman. What is the evidence that tumors are angiogenesis dependent? , 1990, Journal of the National Cancer Institute.
[132] P H Burri,et al. Scanning electron microscope study of the developing microvasculature in the postnatal rat lung , 1986, The Anatomical record.
[133] J. Folkman,et al. Mast cells and tumor angiogenesis , 1976, International journal of cancer.
[134] R. G. Berry,et al. Chorioallantoic membrane heterotransplantation of human brain tumors , 1975, International journal of cancer.
[135] J. Folkman. Tumor angiogenesis: therapeutic implications. , 1971, The New England journal of medicine.
[136] F. Becker,et al. Growth and metastasis of tumor in organ culture , 1963, Cancer.
[137] H. W. Chalkley,et al. Vascular reactions of normal and malignant tissues in vivo. III. Vascular reactions' of mice to fibroblasts treated in vitro with methylcholanthrene. , 1950, Journal of the National Cancer Institute.
[138] O. Warburg,et al. THE METABOLISM OF TUMORS IN THE BODY , 1927, The Journal of general physiology.
[139] Michael Schwenk,et al. Tumor , 1828, The London medical and physical journal.
[140] H. Spaink,et al. Imaging Cancer Angiogenesis and Metastasis in a Zebrafish Embryo Model. , 2016, Advances in experimental medicine and biology.
[141] Izhak Haviv,et al. Co-evolution of tumor cells and their microenvironment. , 2009, Trends in genetics : TIG.
[142] A. Peled,et al. CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers , 2009, Leukemia.
[143] F. Orsenigo,et al. Organization and signaling of endothelial cell-to-cell junctions in various regions of the blood and lymphatic vascular trees , 2008, Cell and Tissue Research.
[144] Valentin Djonov,et al. New insights into intussusceptive angiogenesis. , 2005, EXS.
[145] C. Turner,et al. JCB Article , 2001 .
[146] E. Hirsch,et al. Tissue-specific KO of ECM proteins. , 2000, Methods in molecular biology.
[147] Lars Holmgren,et al. Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression , 1995, Nature Medicine.
[148] D. C. Henckel,et al. Case report. , 1995, Journal.
[149] S. Paku,et al. First steps of tumor-related angiogenesis. , 1991, Laboratory investigation; a journal of technical methods and pathology.